Published in Gut on January 01, 2000
Antimicrobial Therapy for Ulcerative Colitis (UC) (UC) | NCT03986996
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol (2002) 2.05
Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut (2004) 1.77
Molecular ecological analysis of the succession and diversity of sulfate-reducing bacteria in the mouse gastrointestinal tract. Appl Environ Microbiol (2000) 1.71
Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol (2011) 1.65
Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut (2004) 1.63
Gut microbiota and inflammation. Nutrients (2011) 1.60
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol (2006) 1.53
H2S and its role in redox signaling. Biochim Biophys Acta (2014) 1.44
Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc Natl Acad Sci U S A (2013) 1.44
Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis. World J Surg (2010) 1.41
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut (2007) 1.29
Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol (2012) 1.26
Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol (2012) 1.24
Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid Redox Signal (2011) 1.13
Bacterial symbioses of the medicinal leech Hirudo verbana. Gut Microbes (2012) 1.06
Mucosal protection against sulphide: importance of the enzyme rhodanese. Gut (2002) 1.02
The gut microbiota and inflammatory bowel disease. Semin Immunopathol (2014) 1.01
The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes (2011) 0.98
Hydrogen sulfide signaling in the gastrointestinal tract. Antioxid Redox Signal (2013) 0.97
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int (2013) 0.95
Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci (2012) 0.92
An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect Immun (2004) 0.92
Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev (2015) 0.91
A short-oligonucleotide microarray that allows improved detection of gastrointestinal tract microbial communities. BMC Microbiol (2008) 0.91
Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes (2016) 0.87
Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol Gastrointest Liver Physiol (2015) 0.85
Diet and relapsing ulcerative colitis: take off the meat? Gut (2004) 0.84
Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. Dig Dis Sci (2001) 0.83
Overestimation of the abundance of sulfate-reducing bacteria in human feces by quantitative PCR targeting the Desulfovibrio 16S rRNA gene. Appl Environ Microbiol (2011) 0.83
The cytochrome bd oxidase of Escherichia coli prevents respiratory inhibition by endogenous and exogenous hydrogen sulfide. Mol Microbiol (2016) 0.83
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol (2016) 0.82
Hydrogenotrophic microbiota distinguish native Africans from African and European Americans. Environ Microbiol Rep (2012) 0.82
Impaired detoxication of hydrogen sulfide in ulcerative colitis? Dig Dis Sci (2007) 0.82
Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract. Microorganisms (2015) 0.81
Escherichia coli cytochrome c peroxidase is a respiratory oxidase that enables the use of hydrogen peroxide as a terminal electron acceptor. Proc Natl Acad Sci U S A (2017) 0.80
H2 S modulates duodenal motility in male rats via activating TRPV1 and K(ATP) channels. Br J Pharmacol (2014) 0.79
Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut (2017) 0.77
A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis. PLoS One (2015) 0.77
The murine appendiceal microbiome is altered in spontaneous colitis and its pathological progression. Gut Pathog (2014) 0.77
Emerging Roles of Hydrogen Sulfide in Inflammatory and Neoplastic Colonic Diseases. Front Physiol (2016) 0.76
Xylo-oligosaccharides and inulin affect genotoxicity and bacterial populations differently in a human colonic simulator challenged with soy protein. Nutrients (2013) 0.75
Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota. FEMS Microbiol Ecol (2016) 0.75
Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation. Mol Syst Biol (2017) 0.75
Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa? Nutrients (2017) 0.75
Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 19.22
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell (1993) 11.95
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 6.61
Natural relationships among sulfate-reducing eubacteria. J Bacteriol (1989) 5.35
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut (1980) 4.24
Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology (1982) 3.92
The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet (1980) 3.32
Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol (1992) 2.87
Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol (1988) 2.71
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut (1990) 2.13
Ileal symbiont intracellularis, an obligate intracellular bacterium of porcine intestines showing a relationship to Desulfovibrio species. Int J Syst Bacteriol (1993) 2.01
Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology (1978) 1.98
Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut (1994) 1.96
Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol (1998) 1.87
Metabolism of dietary sulphate: absorption and excretion in humans. Gut (1991) 1.85
Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology (1968) 1.80
Genetics of inflammatory bowel disease. Gut (1994) 1.79
Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75
Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide. Biochem Pharmacol (1980) 1.64
Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology (1993) 1.58
Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol (1994) 1.58
Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut (1996) 1.52
Breath methane and large bowel cancer risk in contrasting African populations. Gut (1988) 1.50
Acetate production from hydrogen and [13C]carbon dioxide by the microflora of human feces. Appl Environ Microbiol (1988) 1.44
Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut (1980) 1.37
Physiology and ecology of the sulphate-reducing bacteria. J Appl Bacteriol (1990) 1.36
Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut (1995) 1.34
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut (1997) 1.32
Methanogens outcompete sulphate reducing bacteria for H2 in the human colon. Gut (1994) 1.32
Factors affecting hydrogen production and consumption by human fecal flora. The critical roles of hydrogen tension and methanogenesis. J Clin Invest (1992) 1.30
Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut (1995) 1.26
Competition for hydrogen by human faecal bacteria: evidence for the predominance of methane producing bacteria. Gut (1991) 1.24
A novel mucin sulphatase from human faeces: its identification, purification and characterization. Clin Sci (Lond) (1992) 1.23
Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology (1994) 1.21
Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut (1996) 1.20
Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett (1992) 1.18
Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 1.12
Salicylates for ulcerative colitis--their mode of action. Pharmacol Ther (1994) 1.03
Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. Gut (1987) 1.02
Hydrogen sulphide and total acid-volatile sulphide in faeces, determined with a direct spectrophotometric method. Clin Chim Acta (1991) 0.99
Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood. Dig Dis Sci (1998) 0.97
Decreased sulphur aminoacid intake in ulcerative colitis. Lancet (1998) 0.94
Detoxication of sodium 35 S-sulphide in the rat. Biochem Pharmacol (1972) 0.93
[Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.92
Mechanism of action of 5-aminosalicylic acid and its derivatives. Clin Sci (Lond) (1990) 0.90
Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci (1998) 0.86
Study of constancy of hydrogen-consuming flora of human colon. Dig Dis Sci (1994) 0.85
Short-chain fatty acid enemas in the treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol (1997) 0.85
Hydrogen sulphide produces diminished fatty acid oxidation in the rat colon in vivo: implications for ulcerative colitis. Aust N Z J Surg (1997) 0.84
Use of metabolic inhibitors to study H2 consumption by human feces: evidence for a pathway other than methanogenesis and sulfate reduction. J Lab Clin Med (1993) 0.83
Ventricular expression and circulating levels of immunoreactive dynorphin in heart transplant recipients. Clin Sci (Lond) (1993) 0.81
Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr (1992) 4.84
Measurement of the mean transit time of dietary residue through the human gut. Gut (1976) 4.22
Short chain fatty acids in the human colon. Gut (1981) 3.49
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology (1995) 3.26
Short chain fatty acid absorption by the human large intestine. Gut (1978) 2.87
Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol (1992) 2.87
Functional food science and gastrointestinal physiology and function. Br J Nutr (1998) 2.78
Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol (1988) 2.71
Intakes and sources of dietary fiber in the British population. Am J Clin Nutr (1979) 2.58
Transit through the gut measured by analysis of a single stool. Gut (1976) 2.36
Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology (1992) 2.34
Colonic response to dietary fibre from carrot, cabbage, apple, bran. Lancet (1978) 2.33
The microbial contribution to human faecal mass. J Med Microbiol (1980) 2.26
Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut (1990) 2.13
The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr (1979) 2.06
Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut (1993) 2.05
Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol (1988) 1.97
Changes in fecal composition and colonic function due to cereal fiber. Am J Clin Nutr (1976) 1.91
Protein degradation by human intestinal bacteria. J Gen Microbiol (1986) 1.90
Determination of the non-starch polysaccharides in plant foods by gas-liquid chromatography of constituent sugars as alditol acetates. Analyst (1982) 1.89
Metabolism of dietary sulphate: absorption and excretion in humans. Gut (1991) 1.85
Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J Clin Invest (1985) 1.77
Dietary fibre. Gut (1973) 1.77
Urine nitrogen as an independent validatory measure of dietary intake: a study of nitrogen balance in individuals consuming their normal diet. Am J Clin Nutr (1985) 1.75
Fermentation in the human large intestine and the available substrates. Am J Clin Nutr (1987) 1.67
Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis (1996) 1.65
Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ (1999) 1.65
Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut (2004) 1.63
FAO/WHO scientific update on carbohydrates in human nutrition: conclusions. Eur J Clin Nutr (2007) 1.60
Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther (2006) 1.59
Role of the colon in ileal-resection diarrhoea. Lancet (1973) 1.58
Digestion of polysaccharides of potato in the small intestine of man. Am J Clin Nutr (1987) 1.58
Mechanism of action of dietary fibre in the human colon. Nature (1980) 1.57
The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin Sci (Lond) (1983) 1.56
Laxative abuse. Gut (1974) 1.54
Use of a three-stage continuous culture system to study the effect of mucin on dissimilatory sulfate reduction and methanogenesis by mixed populations of human gut bacteria. Appl Environ Microbiol (1988) 1.53
Digestion of the carbohydrates of banana (Musa paradisiaca sapientum) in the human small intestine. Am J Clin Nutr (1986) 1.52
Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut (1996) 1.52
Breath methane and large bowel cancer risk in contrasting African populations. Gut (1988) 1.50
Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr (1997) 1.48
Effect of changing transit time on colonic microbial metabolism in man. Gut (1987) 1.47
Fermentation in the human large intestine: evidence and implications for health. Lancet (1983) 1.46
The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects. Br J Nutr (1986) 1.44
Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut (2004) 1.41
Colonic microflora: nutrition and health. Nutrition (1997) 1.39
Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr (2000) 1.35
Effect of intravenous prostaglandin F 2 on small intestinal function in man. Nature (1973) 1.35
Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J Clin Invest (1978) 1.32
Digestion of the polysaccharides of some cereal foods in the human small intestine. Am J Clin Nutr (1985) 1.31
Starch intake and colorectal cancer risk: an international comparison. Br J Cancer (1994) 1.29
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut (2004) 1.26
The digestion of pectin in the human gut and its effect on calcium absorption and large bowel function. Br J Nutr (1979) 1.25
Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut (1992) 1.24
Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr (1996) 1.23
Measurement of resistant starch in vitro and in vivo. Br J Nutr (1996) 1.23
Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response. Am J Clin Nutr (1999) 1.22
Contribution of the microflora to proteolysis in the human large intestine. J Appl Bacteriol (1988) 1.21
The diet of individuals: a study of a randomly-chosen cross section of British adults in a Cambridgeshire village. Br J Nutr (1981) 1.21
Colonic and small intestinal response to intravenous prostaglandin F2 alpha and E2 in man. Gut (1975) 1.19
Constipation, dietary fibre and the control of large bowel function. Postgrad Med J (1984) 1.19
Improved method for measurement of dietary fiber as non-starch polysaccharides in plant foods. J Assoc Off Anal Chem (1988) 1.18
The influence of a diet rich in wheat fibre on the human faecal flora. J Med Microbiol (1976) 1.18
The contribution of the large intestine to blood acetate in man. Clin Sci (Lond) (1991) 1.18
Dietary fibre. Br Med Bull (1981) 1.17
Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol Suppl (1984) 1.16
The use of creatinine output as a check on the completeness of 24-hour urine collections. Hum Nutr Clin Nutr (1985) 1.15
Possible implications for health of the different definitions of dietary fibre. Nutr Metab Cardiovasc Dis (2009) 1.13
Nutritional aspects of dissimilatory sulfate reduction in the human large intestine. Curr Microbiol (1997) 1.12
A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta (2000) 1.10
Microbial digestion of complex carbohydrates in man. Proc Nutr Soc (1984) 1.10
Growth of a human intestinal Desulfovibrio desulfuricans in continuous cultures containing defined populations of saccharolytic and amino acid fermenting bacteria. J Appl Microbiol (1998) 1.09
Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates. Eur J Clin Nutr (2007) 1.07
Effect of pectin, guar gum, and wheat fibre on serum-cholesterol. Lancet (1975) 1.06
Effect of exercise and physical fitness on large intestinal function. Gastroenterology (1989) 1.06
Dietary fibre consumption in Britain: new estimates and their relation to large bowel cancer mortality. Br J Cancer (1985) 1.04
Laxative-induced diarrhoea: a continuing clinical problem. Br Med J (1974) 1.03
Reference values for analytes of 24-h urine collections known to be complete. Ann Clin Biochem (1988) 1.03
Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol (1989) 1.02
Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res (1998) 1.02
Nitrogen losses from the human small bowel: obligatory losses and the effect of physical form of food. Gut (1988) 1.02
The role of dietary fibre in the human colon. Can Med Assoc J (1980) 1.01
Dietary fibre and colonic function. J R Soc Med (1978) 1.00
Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood. Dig Dis Sci (1998) 0.97
Cellulose and the human gut. Gut (1984) 0.97
Impaired hydrogen metabolism in pneumatosis cystoides intestinalis. Gastroenterology (1993) 0.96
Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin. J Lab Clin Med (1987) 0.95
Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease. Aliment Pharmacol Ther (2010) 0.95
Water-holding by dietary fibre in vitro and its relationship to faecal output in man. Gut (1979) 0.95
Does digestibility of meat protein help explain large bowel cancer risk? Nutr Cancer (1995) 0.95
Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev (1995) 0.94
Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol (1990) 0.94
Effect of wheat fiber on blood lipids, fecal steroid excretion and serum iron. Am J Clin Nutr (1975) 0.93
Starch and non-starch polysaccharides in some cereal foods. J Sci Food Agric (1983) 0.93
Mucosal bacteria in ulcerative colitis. Br J Nutr (2005) 0.92
Hypocholesterolemic action of dietary fiber unrelated to fecal bulking effect. Am J Clin Nutr (1979) 0.91
Comparison of radio-opaque pellets and chromium sesquioxide as inert markers in studies requiring accurate faecal collections. Gut (1978) 0.90